Get the Stockscreener App
87.47
0.04%
0.095
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Medtronic Plc stock is traded at $87.47, with a volume of 2.56M.
It is up +0.04% in the last 24 hours and down -12.14% over the past month.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
See More
Previous Close:
$87.38
Open:
$87.66
24h Volume:
2.56M
Relative Volume:
0.33
Market Cap:
$112.33B
Revenue:
$35.48B
Net Income/Loss:
$4.64B
P/E Ratio:
24.42
EPS:
3.582
Net Cash Flow:
$5.41B
1W Performance:
-3.83%
1M Performance:
-12.14%
6M Performance:
-7.03%
1Y Performance:
-5.32%
1-Day Range:
$87.20
$88.56
1-Week Range:
$87.20
$91.54
52-Week Range:
$79.55
$106.33
Medtronic Plc Stock (MDT) Company Profile
Name
Medtronic Plc
Sector
Industry
Phone
01135314381700
Address
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT vs ABT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
87.49 | 112.19B | 35.48B | 4.64B | 5.41B | 3.582 |
|
ABT
Abbott Laboratories
|
108.11 | 187.91B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
340.82 | 129.05B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
BSX
Boston Scientific Corp
|
68.73 | 101.72B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.24 | 49.14B | 6.07B | 1.06B | 1.34B | 1.8063 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-13-26 | Resumed | Barclays | Overweight |
| Feb-09-26 | Upgrade | Needham | Hold → Buy |
| Feb-03-26 | Resumed | Citigroup | Buy |
| Jan-30-26 | Resumed | Wells Fargo | Overweight |
| Jan-06-26 | Upgrade | William Blair | Mkt Perform → Outperform |
| Nov-19-25 | Upgrade | Goldman | Sell → Neutral |
| Jun-30-25 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Oct-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-21-24 | Reiterated | Oppenheimer | Perform |
| Aug-15-24 | Upgrade | UBS | Sell → Neutral |
| Aug-14-24 | Downgrade | Stifel | Buy → Hold |
| May-30-24 | Initiated | Goldman | Sell |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-24-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-29-23 | Downgrade | UBS | Buy → Sell |
| Jan-09-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-23-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-23-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-16-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Aug-24-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Jun-01-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-17-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Jun-10-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Dec-15-20 | Upgrade | Goldman | Sell → Neutral |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-08-20 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-08-20 | Upgrade | Stifel | Hold → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| May-14-20 | Downgrade | DZ Bank | Buy → Hold |
| Mar-30-20 | Downgrade | Needham | Strong Buy → Buy |
| Mar-25-20 | Upgrade | DZ Bank | Hold → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Sell |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-02-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jun-05-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Feb-04-19 | Reiterated | Needham | Strong Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-27-18 | Reiterated | Argus | Buy |
View All
Medtronic Plc Stock (MDT) Latest News
Employees Retirement System of Texas Has $84.88 Million Stock Position in Medtronic PLC $MDT - MarketBeat
Peripheral Vascular Disease Market Is Going to Boom | Medtronic • Boston Scientific • Abbott Laboratories - openPR.com
SageView Advisory Group LLC Increases Stock Position in Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Position Lifted by Quadrant Capital Group LLC - MarketBeat
Orthobiologics Market to Surpass USD 9 Billion by 2031 Amid Rising Osteoarthritis Cases and Advancements in Regenerative Therapies, Says Mordor Intelligence - GlobeNewswire Inc.
Sutures Market Set for Dynamic Boom as Key Players Medtronic Plc, Johnson & Johnson, and SMI - openPR.com
Medtronic (MDT) Announces Quarterly Dividend of $0.71 per Share - Insider Monkey
Medtronic unit raises $560 million in US IPO priced below range - MSN
Medtronic elevates Sean Haag to president of ENT - MedTech Dive
Electronic Pill Market Is Going to Boom Rapidly | Medtronic plc, CapsoVision Inc., IntroMedic Co. Ltd. - openPR.com
Franklin Resources Inc. Sells 277,033 Shares of Medtronic PLC $MDT - MarketBeat
Mackenzie Financial Corp Reduces Holdings in Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Bought by Private Advisor Group LLC - MarketBeat
Medtronic PLC $MDT Shares Purchased by Capital World Investors - MarketBeat
Leerink, Needham Maintain Outperform and Buy on Medtronic plc (MDT) Mar 2026 - Meyka
Deep Dive Into Medtronic Stock: Analyst Perspectives (10 Ratings) - Benzinga
Medtronic to strengthen neurovascular business with $550m Scientia Vascular acquisition - Medical Device Network
Medtronic to acquire Scientia Vascular for $550M - MedTech Dive
Medtronic's $550 Million Scientia Vascular Deal Aims To Boost Neurovascular Portfolio - Benzinga
Truist reiterates Hold on Medtronic stock after acquisition deal - Investing.com India
Medtronic Spark Onsite: A Day of Innovation, Collaboration, and Discovery - CSRwire
Medtronic : Sean Haag named president of the Medtronic Ear, Nose, & Throat business - marketscreener.com
Medtronic PLC $MDT Position Boosted by Van ECK Associates Corp - MarketBeat
Richard Bernstein Advisors LLC Lowers Position in Medtronic PLC $MDT - MarketBeat
Medtronic to buy Scientia Vascular in $550 million deal - Reuters
Medtronic PLC $MDT Shares Sold by Capital Research Global Investors - MarketBeat
Legal & General Group Plc Acquires 827,530 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic to acquire Scientia Vascular, marrying access and therapeutic portfolios for neurovascular care - marketscreener.com
Medtronic to acquire Scientia Vascular for $550 million - Investing.com India
Grantham Mayo Van Otterloo & Co. LLC Has $4.87 Million Position in Medtronic PLC $MDT - MarketBeat
First Trust Advisors LP Has $89.69 Million Stock Position in Medtronic PLC $MDT - MarketBeat
MiniMed completes $538M IPO, retains $309M in proceeds as Medtronic separation takes shape - Drug Delivery Business
MiniMed closes $560M IPO, Medtronic retains 90% stake - Investing.com
Knee Replacement Market May See a Big Move | Major Giants- Medtronic, Exactech, Medacta - openPR.com
Swiss National Bank Decreases Stock Position in Medtronic PLC $MDT - MarketBeat
Schroder Investment Management Group Has $717.14 Million Stake in Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Sold by Russell Investments Group Ltd. - MarketBeat
Medtronic PLC $MDT Shares Sold by Kiltearn Partners LLP - MarketBeat
ProVise Management Group LLC Increases Position in Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Bought by Vinva Investment Management Ltd - MarketBeat
Rhenman & Partners Asset Management AB Acquires 25,500 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic PLC $MDT Shares Acquired by Natixis Advisors LLC - MarketBeat
IFG Advisory LLC Sells 28,471 Shares of Medtronic PLC $MDT - MarketBeat
Medtronic’s MiniMed goes public for $560M - MedTech Dive
Medtronic (MDT): MiniMed IPO Priced Below Expectations - GuruFocus
Medtronic’s diabetes unit MiniMed drops on trading debut - Seeking Alpha
Cleary, Davis Polk Lead Diabetes Biz Minimed's $560M IPO - Law360
Medtronic (MDT) Subsidiary MiniMed Group Prices IPO Below Expectations - GuruFocus
Medtronic's MiniMed falls in Nasdaq debut, fetches $5.35 billion in valuation - Reuters
Minimed IPO raises $560M as it splits from Medtronic - bioworld.com
RSI Alert: Medtronic Now Oversold - Nasdaq
Medtronic Plc Stock (MDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.20%
2.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):